Transcatheter aortic valve implantation in a young heart transplant recipient crossing the traditional boundaries

J Thorac Dis. 2016 Aug;8(8):E711-4. doi: 10.21037/jtd.2016.07.61.

Abstract

Transcatheter aortic valve implantation (TAVI) is an established therapeutic alternative to surgical aortic valve replacement (SAVR) in high-risk or inoperable patients with symptomatic aortic valve stenosis. Hitherto, TAVI is not recommended in young and low-intermediate risk patients. However, TAVI may also serve as an alternative to SAVR in selected young patients, e.g., patients who have previously undergone multiple cardiac surgery procedures. We report a case of trans-femoral TAVI in a 25-year-old heart transplant (HTx) recipient with prior surgery for congenital heart disease.

Keywords: Aorta stenosis; heart transplant (HTx); transcatheter aortic valve implantation (TAVI).

Publication types

  • Case Reports